Quest Diagnostics (DGX) Equity Ratio (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Equity Ratio data on file, last reported at 0.46 in Q1 2026.

• Quarterly Equity Ratio rose 4.33% year-over-year to 0.46 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.46 (up 4.33% YoY) and the FY2025 annual result came in at 0.44, up 4.77% from the prior year.
• Equity Ratio climbed to 0.46 in Q1 2026 per DGX's latest filing, from 0.44 in the prior quarter.
• The five-year high for Equity Ratio was 0.48 in Q2 2022, with the low at 0.42 in Q4 2024.
• Average Equity Ratio over 5 years is 0.46, with a median of 0.46 recorded in 2022.
• Year-over-year, Equity Ratio declined 11.34% in 2024 and climbed 5.43% in 2025.
• Quest Diagnostics' Equity Ratio stood at 0.46 in 2022, then retreated by 2.09% to 0.45 in 2023, then slipped by 6.75% to 0.42 in 2024, then climbed by 4.77% to 0.44 in 2025, then increased by 4.04% to 0.46 in 2026.
• Business Quant data shows DGX's Equity Ratio at 0.46 in Q1 2026, 0.44 in Q4 2025, and 0.45 in Q3 2025.